C227-0283 Screening compound: N'-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(4-methylpiperidin-1-yl)quinolin-6-yl]butanediamide

C227-0283 Screening compound: N'-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(4-methylpiperidin-1-yl)quinolin-6-yl]butanediamide
C227-0283 Screening compound: N'-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(4-methylpiperidin-1-yl)quinolin-6-yl]butanediamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C227-0283
N'-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(4-methylpiperidin-1-yl)quinolin-6-yl]butanediamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C227-0283

Molecular Formula

C33H43ClN6O2 (C33 H43 ClN6 O2)

Compound Name

N'-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(4-methylpiperidin-1-yl)quinolin-6-yl]butanediamide

IUPAC name

N'-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(4-methylpiperidin-1-yl)quinolin-6-yl]butanediamide

SMILES

CC(CC1)CCN1c1cc(C)c(cc(cc2)NC(CCC(NCCCN(CC3)CCN3c3cccc(Cl)c3)=O)=O)c2n1

InChI

InChI=1S/C33H43ClN6O2/c1-24-11-15-40(16-12-24)31-21-25(2)29-23-27(7-8-30(29)37-31)36-33(42)10-9-32(41)35-13-4-14-38-17-19-39(20-18-38)28-6-3-5-26(34)22-28/h3,5-8,21-24H,4,9-20H2,1-2H3,(H,35,41)(H,36,42)

InChI Key

JBYFYWZKBBYUFY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14733610

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

591.2

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.168

Distribution Coefficient, logD

4.582

Water Solubility, LogSw

-5.39

Polar Surface Area

65.919

Acid Dissociation Constant (pKa)

11.10

Base Dissociation Constant (pKb)

7.86

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

48.50

C227-0283 in Drug Discovery

Included in Screening Libraries

Lipid Metabolism Library (9174 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cardiovascular
  • Metabolic
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with C227-0283 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C227-0283?
Check Price and Availability of C227-0283, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C227-0283 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C227-0283
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C227-0283
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C227-0283 available by request